Bowen Acquisition Corp Receives NASDAQ Delisting Notification for Failure to Comply with Listing Requirements

Core Viewpoint - Bowen Acquisition Corp (BOWN) is facing potential delisting from the Nasdaq Global Market due to non-compliance with several listing rules [1][2]. Group 1: Delisting Determination - BOWN received a delisting determination letter on July 15, 2025, indicating non-compliance with Nasdaq Listing Rules, including a Market Value of Listed Securities below $50 million for 30 consecutive trading days [1][2]. - Specific non-compliance issues include failing to maintain a minimum of 1,100,000 publicly held shares and a Market Value of Publicly Held Shares below $15 million for the required period [2]. - BOWN has until 4:00 p.m. Eastern Time on July 22, 2025, to appeal the delisting determination, or trading will be suspended on July 24, 2025 [3][4]. Group 2: Appeal Process - If BOWN requests a hearing, the suspension of its securities will be stayed for 15 days from the request date, and the hearing panel will review the request for an extended stay [4]. - The company intends to appeal the delisting determination and request a stay of the suspension, although there is no guarantee that the panel will grant these requests [5]. Group 3: Business Combination Efforts - BOWN is actively working to complete a business combination with Shenzhen Qianzhi BioTechnology Co., Ltd., believing this will help it regain compliance with Nasdaq listing requirements [6]. - The company is a blank check entity focused on mergers and similar business combinations, with a definitive agreement already in place for the transaction with Shenzhen Qianzhi [7].